The report on the Global Apoptosis Assays Market published by Value Market Research states that the market was valued close to USD 3753.8 MN in 2019 and is anticipated to reach USD 7301.8 MN by 2026 along with a CAGR of 10.6% in the forecasted period within 2020 to 2026. The rise in the count of the population that is suffering from cancer, autoimmune diseases and neurodegenerative diseases is a major driver responsible for the growth of the global apoptosis assays market. The increase in the expenditure by the government spent on cancer research has again resulted in an increase in the growth of the market. The rise in the demand for high content screening and drug development especially for cancer is also responsible for the growth of the global apoptosis assays market.
Apoptosis is the programmed death of cells performed by the cells characterized by the compaction of the nucleus, shrinkage of the cell cytoplasm, DNA fragmentation and cleavage of cellular proteins. Apoptosis is a controlled cell ablation that occurs naturally as it is a part of the cell lifecycle. It is also observed through flow cytometry, spectrometry and various other techniques used in research institutes and diagnostic laboratories. Various assays such as caspase assays, DNA fragmentation assays, cell permeability assays and mitochondrial assays are used to detect apoptosis in the cell population. Various assays such as caspase assays, DNA fragmentation assays, cell permeability assays, and mitochondrial assays are used to detect apoptosis in the cell population.
The report “Global Apoptosis Assays Market Report By Product (Assay Kits, Reagents, Instruments And Micro Plates), By Detection Technology (Flow Cytomerty, Cell Imaging & Technology, Spectrophotometry And Other Detection Technologies), By Application (Drug Discovery & Development, Clinical Diagnostic Application, Basic Approach And Stem Cell Research), By End-User (Pharmaceutical & Biotechnological Companies, Hospital & Diagnostic Laboratories, And Academic & Research Institutes) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026” covers the global apoptosis assays market with a complete industry overview and analysis.
By product, assay kits, reagents, instruments and microplates are the segments of the global apoptosis assays market. Assay kits segment accounts for the largest market share as it holds high demand in research related to pathway of diseases, potential drug screening etc. These are easy to use and convenient and are available in various formats. By detection technology, flow cytometry, cell imaging & technology and spectrophotometry are the classifications provided for the global apoptosis assays market as per the report.
By application, drug discovery & development, clinical diagnostic application, basic approach and stem cell research are the classifications provided for the global apoptosis assays market. Discovery and development segment account for largest share by application as high investment is made in this segment . By end-user, pharmaceutical & biotechnological companies, hospital & diagnostic laboratories and academic & research institutes are the classifications provided for the global apoptosis assays market. Pharmaceutical and biotechnology segment is the leading segment.
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa are the regional segments of the global apoptosis assays market as per the report. High volume of advance scientific studies, rising prevalence of chronic & infectious diseases has led to the dominance of North American region in this market. Moreover high government support and state-of-art infrastructure required for R&D are other factors contributing to the growth of apoptosis assays market in North America.
The Report Segments Global Apoptosis Assays Market -
By Detection Technology
Players Profiled In the Report:
Abcam PLC, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne Corporation, Biotek Instruments, Biotium, Creative Bioarray (A Part of Creative Dynamics Inc.), Danaher Corporation, GE Healthcare, GeneCopoeia, Inc., Geno Technology, Inc., Merck KGaA, PerkinElmer, Promega Corporation, Sartorius AG and Thermo Fisher Scientific Inc.
About Value Market Research:
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]
Avail customized purchase options to meet your exact research needs:
" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "
" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "
" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "